Fed Probes Morgan Stanley’s International Wealth-Management Practices
At issue is how the bank vets foreigners and the origins of their money before taking them on as customers.Read More
Democrats Spent Heavily on Abortion Ads, Leaning Into Searing Details
Graphic details and shock value used to characterize Republican political ads on abortion. But Democrats ran explicit, visceral ads ahead of Tuesday’s elections, and it paid off.Read More
Tuesday Was Great for Democrats. It Doesn’t Change the Outlook for 2024.
A pattern continued with success in low-turnout elections, which favors highly engaged voters. Presidential years tend to be different.Read More
Israel Raises Alarms by Suggesting ‘Indefinite’ Role in Gaza
Secretary of State Antony J. Blinken quickly pushed back, but what exactly comes next is far from clear.Read More
China Is Becoming a Problem for Investors
U.S.-listed companies that do a lot of business in the country have struggled.Read More
China Is Becoming a Problem for Investors
U.S.-listed companies that do a lot of business in the country have struggled.Read More
House Republicans Subpoena Biden’s Son and Brother in Impeachment Inquiry
Representative James Comer, the chairman of the Oversight Committee, demanded testimony from James Biden and Hunter Biden as he hunts for evidence of bribery and corruption by the president.Read More
Citigroup Fined for Discriminating Against Armenian Americans
The bank will pay $25.9 million in fines and redress to consumers after illegally discriminating against credit card applicants that the bank identified as Armenian American, according to regulators.Read More
Robinhood No Longer Looks Like a Steal
The upstart is still well short of the big boys in the brokerage business as “YOLO” traders continue to retrench.Read More
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in the diabetes drug Mounjaro.Read More
